{
  "retracted": false,
  "timestamp": 1572912000000,
  "updates": [
    {
      "timestamp": 1591682914870,
      "identifier": {
        "doi": "10.1007/s11060-019-03331-8"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s11060-019-03277-x"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016"
}
